283 filings
Page 8 of 15
6-K
5kuk5e9zho
26 Jul 18
Current report (foreign)
7:00am
6-K
cg0l0 1qjis5u1b
10 Jul 18
Kamada Receives Positive Scientific Advice from European Medicines Agency
7:00am
6-K
l5jdgbzg
4 Jun 18
Results of Kamada’s Phase 2 Trial of Alpha-1 Antitrypsin in Newly
12:00am
6-K
xkopii
15 May 18
Kamada Reports Financial Results for First Quarter of 2018
7:01am
6-K
sj4r hjzjes
9 May 18
Current report (foreign)
7:04am
6-K
iexw7ept4bny2
8 May 18
Kedrion Biopharma and Kamada Announce KEDRAB® (Rabies Immune Globulin [Human]) Now
7:00am
6-K
p0m9 d5fl
23 Apr 18
Kamada Received Feedback from FDA on Proposed Phase 3
12:00am
6-K
bkvlqu
7 Feb 18
Kamada Reports Financial Results for Fourth Quarter and Full-Year 2017
12:00am
6-K
v9eup0iaonsevfyc
8 Jan 18
Kamada Announces Interim Results from Phase 2 Clinical Trial of
12:00am
6-K
are9og50xbtq wo
4 Jan 18
Kamada Announces Collaboration with a Consortium of Prominent
12:00am
6-K
85fh ujhvs9q
30 Nov 17
Current report (foreign)
12:00am
6-K
4hdq kzx1
21 Nov 17
Kamada Announces New Supply Agreement with International Organization
12:00am
6-K
g7omq7oj
20 Nov 17
Kamada and Chiesi Farmaceutici S.p.A. Mutually Agree to
12:00am
6-K
3h7faxhwqc h49kw
13 Nov 17
Current report (foreign)
12:00am
6-K
gj9d kimnw2
13 Nov 17
Kamada Reports Financial Results for Third Quarter and First Nine Months of 2017
12:00am
6-K
ux475ty 4k1
13 Nov 17
Kamada Announces Nomination of Three New Members to its Board of Directors
12:00am
6-K
j8a9jc8xfb8fn
6 Nov 17
Current report (foreign)
12:00am
6-K
13893o4
1 Nov 17
Kamada Announces Top-line Results of Phase 2 Trial of Alpha-1
12:00am
6-K
4us9z9sfdqwa4j ty1ay
26 Oct 17
Notice of 2017 Annual General Meeting of Shareholders
12:00am
6-K
5lixfyfgbwa8
18 Sep 17
Kamada Announces CFO Transition
12:00am